CIAS
BLUE

Capital Investment Advisory Services’s bluebird bio BLUE Stock Holding History

Capital Investment Advisory Services’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-8
Closed -$9K – 631
2019
Q3 		$9K Sell
8
-7
-47% -$10.7K ﹤0.01% 1001
2019
Q2 		$28K Buy
15
+7
+88% +$12.1K 0.01% 688
2019
Q1 		$16K Buy
+8
New +$14.1K 0.01% 731

Other funds holding BLUE

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital Investment Advisory Services's BLUE Position: Q4 2019 in Review

Capital Investment Advisory Services sold out of bluebird bio (BLUE) in Q4 2019, closing a stake of 8 shares — an estimated $9K sold.

Capital Investment Advisory Services first reported a position in BLUE in Q1 2019 and held it in 3 quarters. The position peaked at $28K in Q2 2019. 274 funds tracked by Wall St. Rank hold BLUE as of Q4 2019.

  • Capital Investment Advisory Services reported no remaining bluebird bio position as of Q4 2019 after selling out during the quarter.
  • Capital Investment Advisory Services sold 8 bluebird bio shares in Q4 2019, an estimated $9K.
  • Capital Investment Advisory Services first reported a position in bluebird bio in Q1 2019 and held it in 3 quarters.
  • Capital Investment Advisory Services's bluebird bio position peaked at $28K in Q2 2019.
  • 274 funds tracked by Wall St. Rank held bluebird bio as of Q4 2019.

Based on Capital Investment Advisory Services's 13F filing for Q4 2019, filed 4 Feb 2020.